Effects of endothelin.1 (ET-1) and thrombin antagonism on cardiovascular and respiratory dysfunctions during endotoxic shock in pig

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 67, Issue 6, 2002, Pages 445-451

  Albertini, M ^a   Borromeo, V ^a   Mazzola, S ^a   Ciminaghi, B ^a   Clement, Maria Giovanna ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Igiene e Sanita Pubblica Veterinaria   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; LEPIRUDIN; LIPOPOLYSACCHARIDE; THROMBIN; THROMBIN INHIBITOR; ANTIHYPERTENSIVE AGENT; DRUG DERIVATIVE; FIBRINOLYTIC AGENT; HIRUDIN DERIVATIVE; RECOMBINANT PROTEIN; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HEART OUTPUT; HEART RATE; HYPOTENSION; LUNG COMPLIANCE; LUNG RESISTANCE; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; SEPTIC SHOCK; SWINE; ANIMAL; CARDIOVASCULAR SYSTEM; DRUG ANTAGONISM; DRUG EFFECT; HEMODYNAMICS; LUNG; PATHOPHYSIOLOGY; RESPIRATORY SYSTEM; TIME;

SUS SCROFA;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR SYSTEM; ENDOTHELIN-1; FEMALE; FIBRINOLYTIC AGENTS; HEMODYNAMIC PROCESSES; HIRUDINS; LIPOPOLYSACCHARIDES; LUNG; MALE; RECOMBINANT PROTEINS; RESPIRATORY SYSTEM; SHOCK, SEPTIC; SULFONAMIDES; SWINE; THROMBIN; TIME FACTORS;

EID: 0036893349     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2002.0455     Document Type: Article

References (34)

1. Albertini M., Mazzola S., Clement M. G. Endotoxic shock and cardiac dysfunction: Role of nitric oxide. Biomed Res 2000; 11: 19-26.
2. Albertini M., Ciminaghi B., Mazzola S., Clement M. G. Improvement of respiratory function by bosentan during endotoxic shock in the pig. Prostaglandins Leukot Essent Fatty Acids 2001; 65: 103-108.
3. Eriksson M., Basu S., Larsson A., et al. Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock. Expert Opin Invest Drugs 2000; 9: 1129-1137.
4. Kumar A., Krieger A., Symeoneides S., Kumar A., Parrillo J. E. Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide. J Cardiothorac Vasc Anesth 2001; 15: 485-511.
5. Cicala C., Bucci M., De Dominicis G., Harriot P., Sorrentino L., Cirino G. Bronchonstrictor effect of thrombin and thrombin receptor activating peptide in guinea-pigs in vivo. Br J Pharmacol 1999; 126: 478-484.
6. Lum H., Andersen T. T., Siflinger-Birnboim A., Tiruppathi C., Goligorsky M. S., Malik A. B. Thrombin receptor peptide inhibits thrombin-induced increases in endothelial permeability by receptor desensitization. J Cell Biol 1993; 120: 1491-1499.
7. Cirino G., Cicala C., Bucci M. R., Sorrentino L., Maraganore J. M., Stone S. R. Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med 1996; 183: 821-827.
8. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
9. Barnes P. J. Endothelins and pulmonary diseases. J Appl Physiol 1994; 77: 1051-1059.
10. Carpenter T. C., Stenmark K. R. Endothelin receptor blockade decreases lung water in young rats exposed to viral infection and hypoxia. Am J Physiol 2000; 279: L547-L554.
11. Botting R. M., Vane J. R. Endothelins: Potent releasers of prostacyclin and EDRF. Pol J Pharmacol Pharm 1990; 42: 203-218.
12. Levin E. R. Endothelins. N Engl J Med 1995; 333: 356-63.
13. Woodman R. C., Teoh D., Payne D., Kubes P. Thrombin and leukocyte recruitment in endotoxemia. Am J Physiol Heart Circ Physiol 2000; 279: H1338-H1345.
14. Finsnes F., Christensen G., Lyberg T., Sejersted O. M., Skjømsberg O. H. Increased synthesis and release of endothelin-1 during the initial phase of airway inflammation. Am J Resp Crit Care Med 1998; 158: 1600-1606.
15. Lepailleur-Enouf D., Valdenaire O., Philippe M., Jandrot-Perrus M., Michel J. B. Thrombin induces endothelin expression in arterial smooth muscle cells. Am J Physiol Heart Circ Physiol 2000; 278: H1606-H1612.
16. Bates J. H., Rossi A., Milic-Emili J. Analysis of the behavior of the respiratory system with constant inspiratory flow. J Appl Physiol 1985; 58: 1840-1848.
17. Heras M., Chesebro J. H., Webster M. W., et al. Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis. Circulation 1990; 82: 1476-1484.
18. Fenton J. W. Thrombin functions and antithrombotic intervention. Thromb Haemost 1995; 74: 493-498.
19. Dickneite G., Leithauser B. Influence of antithrombin III on coagulation and inflammation in porcine septic shock. Arterioscler Thromb Vasc Biol 1999; 19: 1566-1572.
20. Weitzberg E., Lunberg J. M., Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 1991; 33: 222-227.
21. Shindo T., Kurihara H., Kurihara Y., Morita H., Yazaki Y. Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model. J Cardiovasc Pharmacol 1998; 31: S541-S544.
22. Yamamoto S., Burman H. P., O'Donnell C. P., Cahill P. A., Robotham J. L. Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock. Am J Physiol 1997; 272: H1239-H1249.
23. Hoffmann H., Siebeck M., Spannagl M., et al. Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs. Am Rev Respir Dis 1990; 142: 782-788.
24. Pinheiro J. M., Andersen T. T., Malik A. B. Receptor mechanism of thrombin-mediated pulmonary vasodilation in neonates. Am J Physiol 1993; 265: L355-L359.
25. Fernandez-Patron C., Radomski M. W., Davidge S. T. Role of matrix metalloproteinase-2 in thrombin induced vasorelaxation of rat mesenteric arteries. Am J Physiol 2000; 278: H1473-H1479.
26. Jaffe E. A., Grulich J., Weksler B. B., Hampel G., Watanabe K. Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells. J Biol Chem 1987; 262: 8557-8565.
27. Pulletz S, Lehmann C., Volk T., et al. Influence of eparin and hirudin on endothelial binding of antithrombin in experimental thrombinemia. Crit Care Med 2000; 28: 2881-2886.
28. Becker R., Merkely B., Bauer A., et al. Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: A comparative analysis using three-dimensional mapping. Cardiovasc Res 2000; 45: 310-320.
29. Wenzel R. R., Fleisch M., Shaw S., et al. Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease. Circulation 1998; 98: 2235-2240.
30. 2+ signalling in the mechanism of thrombin-induced increase in endothelial permeability. Am J Physiol 2001; 280: L239-247.
31. Malik A. B., Fenton J. W. II. Thrombin-mediated increase in vascular endothelial permeability. Semin Thromb Hemost 1992; 18: 193-199.
32. Conforti E., Fenoglio C., Bernocchi G., Bruschi O., Miserocchi G. A. Morpho-functional analysis of lung tissue in mild interstitial edema. Am J Physiol 2002; 282: L766-L774.
33. Guo Y., Cernacek P., Giaid A., Hussain S. N. A. Production of endothelins by the ventilatory muscles in septic shock. Am J Respir Cell Mol Biol 1998; 19: 470-476.
34. Pfau J. C., Walker E., Card G. L. Monoclonal antibodies to CD45 modify LPS-induced arachidonic acid metabolism in macrophages. Biochim Biophys Acta 2000; 1495: 212-222.